
Integer Holdings Corporation
ITGRNYSEHealthcareMedical - Devices
Latest quote
$125.19
−$0.01 · -0.01%
ITGR company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
92
Deep Value
Momentum
46
Neutral
Sentiment
68
Bullish
Risk resilience
70
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteInteger Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Payman Khales
- Listed since
- Sep 29, 2000
- Employees
- 11,000
Market position
- Volume
- 614.24K
- 0.78× average
- Average volume
- 791.19K
- Average daily volume
- Market cap
- 4.25B USD
- Beta
- 0.61
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 4.11B USD
- P/E (TTM)
- 33.93×
- P/B (TTM)
- 2.48×
- P/S (TTM)
- 2.31×
- EV / EBITDA
- 13.98×
- Earnings yield
- 3.77%
- Free cash flow yield
- 3.86%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 23.73%
- Operating margin
- 9.47%
- Net margin
- 6.97%
- Return on equity
- 5.88%
- Return on assets
- 3.01%
- Return on invested capital
- 5.36%
Financial health
- Debt / equity
- 0.79×
- Current ratio
- 3.32×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.85B USD | 1.72B USD | 1.56B USD | 1.33B USD | 1.22B USD |
| Cost of goods sold | 1.42B USD | 1.26B USD | 1.14B USD | 984.63M USD | 884.11M USD |
| Gross profit | 425.81M USD | 461.18M USD | 411.52M USD | 346.65M USD | 336.97M USD |
| Research and development | 46.35M USD | 53.43M USD | 61.97M USD | 59.76M USD | 51.99M USD |
| Selling, general, and administrative | 162.59M USD | 184.33M USD | 171.47M USD | 157.36M USD | 141.69M USD |
| Operating expenses | 216.55M USD | 252.95M USD | 248.2M USD | 233.97M USD | 201.26M USD |
| Interest expense | 42.31M USD | 56.37M USD | 53.37M USD | 37.27M USD | 31.63M USD |
| Depreciation and amortization | 125.95M USD | 109.71M USD | 96.99M USD | 90.9M USD | 81.59M USD |
| Operating income | 209.27M USD | 208.24M USD | 163.32M USD | 112.68M USD | 135.71M USD |
| Net income | 102.76M USD | 119.9M USD | 90.65M USD | 66.38M USD | 96.81M USD |
Company facts updated Aug 24, 2026.
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$118.25
5.55% downsideITGR peers
ETFs holding ITGR
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR258.56M0.23%111.19B USD0.06%$147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI131.43M0.01%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM108.95M0.13%81.62B USD0.19%$299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB94.61M0.05%183.4B USD0.03%$304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR60.09M0.09%68.3B USD0.05%$249.18+0.68%
Vanguard Extended Market ETFVXF47.42M0.05%93.7B USD0.05%$245.53+0.82%
iShares Russell 2000 Value ETFIWN40.15M0.28%14.66B USD0.24%$224.81+0.45%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM39.96M0.23%17.03B USD0.03%$57.28+0.61%
iShares Core S&P Small-Cap ETFIJR- Market value
- 258.56M
- Weight
- 0.23%
- AUM
- 111.19B USD
- Expense ratio
- 0.06%
- Price / 1D
- $147.31+0.64%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 131.43M
- Weight
- 0.01%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 108.95M
- Weight
- 0.13%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Vanguard Morningstar Small-Cap ETFVB- Market value
- 94.61M
- Weight
- 0.05%
- AUM
- 183.4B USD
- Expense ratio
- 0.03%
- Price / 1D
- $304.76+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR- Market value
- 60.09M
- Weight
- 0.09%
- AUM
- 68.3B USD
- Expense ratio
- 0.05%
- Price / 1D
- $249.18+0.68%
Vanguard Extended Market ETFVXF- Market value
- 47.42M
- Weight
- 0.05%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
iShares Russell 2000 Value ETFIWN- Market value
- 40.15M
- Weight
- 0.28%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81+0.45%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM- Market value
- 39.96M
- Weight
- 0.23%
- AUM
- 17.03B USD
- Expense ratio
- 0.03%
- Price / 1D
- $57.28+0.61%
Continue in GoAI
Research ITGRresearch.disclaimer





